Keyphrases
Carcinoma in Situ
20%
Direct Participation
20%
DNA Sequencing
40%
Epidemiological Characteristics
20%
Epstein-Barr Virus
100%
Etiology
100%
Fainting
20%
Growth-stimulating
20%
High-risk Human Papillomavirus (HR-HPV)
100%
HPV16
20%
Immunohistochemical Staining
20%
In Situ Hybridization
20%
Infectious Agents
20%
Lymphocytes
20%
Molecular Probe
20%
Oncogenesis
20%
Plasma Epstein-Barr Virus DNA
20%
Polymerase Chain Reaction Assay
20%
Preinvasive Carcinoma
20%
Protein Drug
20%
Specific Antibodies
20%
Stromal Tissue
20%
Testicular Cancer
20%
Testicular Germ Cell Tumor
100%
Testicular Germ Cells
20%
Testicular Tumor
20%
Virus
40%
Virus Proteins
20%
Medicine and Dentistry
Antibodies
16%
Carcinogenesis
16%
Carcinoma in Situ
33%
DNA Sequence
33%
Epstein Barr Virus
100%
Germinoma
100%
Human Papillomavirus Type 16
16%
in Situ Hybridization
16%
Lymphocyte
16%
Polymerase Chain Reaction
16%
Testis Cancer
16%
Testis Tumor
16%
Viral Protein
16%
Virus DNA
16%
Wart Virus
100%
Immunology and Microbiology
DNA Sequence
33%
DNA Virus
16%
Epstein Barr Virus
100%
Human Papillomavirus Type 16
16%
in Situ Hybridization
16%
Infectious Agent
16%
Lymphocyte
16%
Molecular Probe
16%
Monospecific Antibody
16%
Polymerase Chain Reaction
16%
Viral Protein
16%
Wart Virus
100%